The U.S. Food and Drug Administration (FDA) has cleared Cynosure Lutronic’s XERF system, a radiofrequency (RF) technology for skin tightening.
This device combines 6.78 MHz and 2 MHz frequencies, enabling providers to precisely deliver energy at multiple tissue depths, effectively heating the fibrous septa to generate both immediate and lasting skin-tightening results. The device also features Wave Fit Pulse and Advanced Integrated Cryogen Delivery (ICD) Cooling Technology to regulate energy delivery and maintain optimal surface temperature for a comfortable treatment without the need for numbing. The device has a Spider pattern tip to reduce skin-edge effects.
“As a fellowship-trained cosmetic dermatologist, we prioritize treatments in our clinic that can consistently deliver results with minimal risk and downtime. The XERF system incorporates the newest technology to safely deliver energy deeper down in the skin, while offering intelligent cooling for superior protection and patient comfort,” says Jordan V. Wang, MD, MBE, MBA, the Medical Director of Laser & Skin Surgery Center of Pennsylvania, in a news release.
The XERF device launched in 2024 and is currently sold in Korea, Japan, Hong Kong, and Canada. It is indicated for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. All instances of the term “skin tightening” are used to describe tightening effects that occur via soft tissue coagulation.
